West Pharmaceutical Services Inc.
WST | NYSE
$411.82
-$0.80 (-0.19%)
Nov 2, 2026, 12:52 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 874.5M | 872.3M | 844.9M | 805M | 804.3M | 766.2M | 698.2M | 748.5M | 746.9M | 702M | 695.3M | 732.1M | 747.5M | 754.2M | 715.9M | 708.4M | 686.4M | 771.6M | 719.7M | 729M | 706.6M | 724.1M | 671M |
Cost of Revenue | 527.1M | 543.1M | 548.5M | 501.1M | 510.8M | 493M | 465.5M | 474.1M | 481.7M | 470.7M | 464M | 453.1M | 458M | 462M | 445.3M | 445M | 418.9M | 451.8M | 434.9M | 436.4M | 418.1M | 407.7M | 398.3M |
Gross Profit | 347.4M | 329.2M | 296.4M | 303.9M | 293.5M | 273.2M | 232.7M | 274.4M | 265.2M | 231.3M | 231.3M | 279M | 289.5M | 292.2M | 270.6M | 263.4M | 267.5M | 319.8M | 284.8M | 292.6M | 288.5M | 316.4M | 272.7M |
Operating Income | 267.4M | 179.1M | 177.1M | 156.6M | 173.7M | 158.2M | 128.4M | 170.6M | 167.8M | 130.8M | 127M | 170.6M | 191.1M | 187.3M | 167.5M | 161.8M | 187.6M | 223.9M | 186.8M | 180.9M | 183.5M | 209.9M | 180.3M |
Interest Income | 500K | 1.2M | 3.2M | 5.3M | 4.7M | 3.6M | 4.1M | 4.8M | 4.6M | 4M | 6.2M | 9.4M | 8.8M | 5M | 4.8M | 2.9M | 1.5M | 400K | 300K | 300K | 400K | 200K | 100K |
Pretax Income | 267.7M | 180.1M | 180.1M | 165.4M | 174M | 162M | 113.9M | 166.9M | 168.4M | 133.2M | 131.7M | 171.5M | 190.7M | 189.9M | 163.6M | 131.9M | 141M | 232.7M | 195M | 181.9M | 187.6M | 219.6M | 179.9M |
Net Income | 214M | 154M | 138.8M | 132.1M | 140M | 131.8M | 89.8M | 130.1M | 136M | 111.3M | 115.3M | 137M | 161.3M | 155.1M | 140M | 103M | 120.6M | 188.5M | 173.8M | 147.7M | 175.6M | 187.3M | 151.2M |
Selling & General & Admin | 112.9M | 117.6M | 99.5M | 106.5M | 102.7M | 95.9M | 88M | 85.3M | 81.9M | 83M | 86.7M | 90M | 89M | 88.4M | 86M | 85.7M | 66.3M | 81.5M | 83.4M | 98M | 91.9M | 92.7M | 80.2M |
Research & Development | 18.3M | 19.7M | 15.8M | 21.8M | 17.1M | 19.1M | 16.3M | 18.5M | 15.5M | 17.5M | 17.6M | 18.4M | 16.4M | 16.5M | 17.1M | 15.9M | 13.6M | 14.4M | 14.6M | 13.7M | 13.1M | 13.8M | 12.2M |
Other Expenses | -51.2M | 12.8M | 4M | 18.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 80M | 150.1M | 119.3M | 146.8M | 119.8M | 115M | 104.3M | 103.8M | 97.4M | 100.5M | 104.3M | 108.4M | 98.4M | 104.9M | 103.1M | 101.6M | 79.9M | 95.9M | 98M | 111.7M | 105M | 106.5M | 92.4M |
Interest Expense | n/a | n/a | n/a | n/a | 100K | 100K | 400K | n/a | 700K | 1.5M | 1.5M | 1.1M | 2.9M | 2.6M | 2.2M | 1.6M | 2.1M | 1.8M | 2.1M | 3.1M | 1.7M | 1.8M | 1.8M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 607.1M | 693.2M | 667.8M | 647.9M | 630.6M | 608M | 569.8M | 577.9M | 579.1M | 571.2M | 568.3M | 561.5M | 556.4M | 566.9M | 548.4M | 546.6M | 498.8M | 547.7M | 532.9M | 548.1M | 523.1M | 514.2M | 490.7M |
Income Tax Expense | 58M | 32.2M | 44.7M | 33.3M | 34M | 30.2M | 24.1M | 36.8M | 32.4M | 21.9M | 16.4M | 34.5M | 29.4M | 34.8M | 23.6M | 28.9M | 20.4M | 44.2M | 21.2M | 34.2M | 12M | 32.3M | 28.7M |
Shares Outstanding (Basic) | 70.4M | 70.8M | 72M | 72.3M | 72.3M | 72.3M | 72.5M | 73M | 72.8M | 73M | 73.5M | 74.1M | 74.3M | 74.3M | 74.5M | 74.4M | 74.4M | 74.4M | 74.4M | 74.5M | 74.1M | 74M | 73.9M |
Shares Outstanding (Diluted) | 70.8M | 71.3M | 72.4M | 72.7M | 72.7M | 72.8M | 73M | 73.7M | 73.4M | 73.7M | 74.3M | 75M | 75.3M | 75.4M | 75.7M | 75.6M | 75.7M | 75.8M | 76M | 76.4M | 76M | 75.7M | 75.8M |
EPS (Basic) | 3.04 | 2.17 | 1.93 | 1.83 | 1.94 | 1.82 | 1.24 | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 | 2.09 | 1.88 | 1.38 | 1.62 | 2.53 | 2.34 | 1.98 | 2.37 | 2.53 | 2.04 |
EPS (Diluted) | 3.02 | 2.15 | 1.92 | 1.82 | 1.93 | 1.82 | 1.23 | 1.78 | 1.85 | 1.51 | 1.55 | 1.83 | 2.14 | 2.06 | 1.85 | 1.36 | 1.59 | 2.49 | 2.29 | 1.93 | 2.31 | 2.47 | 1.99 |
EBITDA | 313.6M | 225.3M | 218.5M | 209.5M | 217.1M | 198.5M | 150.9M | 205.6M | 205.4M | 169.1M | 164.5M | 205.2M | 225.6M | 221.6M | 191.7M | 161.4M | 168.1M | 259.1M | 219.1M | 219.4M | 212.8M | 241.6M | 205.8M |
EBIT | 267.7M | 179.1M | 173.9M | 162.5M | 174.1M | 157.1M | 110.9M | 164.9M | 165.2M | 130.2M | 128.9M | 169.3M | 189.9M | 187.5M | 160.1M | 130.3M | 138.3M | 229M | 189.5M | 185M | 182.8M | 212.8M | 176.7M |
Depreciation & Amortization | 45.9M | 46.2M | 44.6M | 47M | 43M | 41.4M | 40M | 40.7M | 40.2M | 38.9M | 35.6M | 35.9M | 35.7M | 34.1M | 31.6M | 31.1M | 29.8M | 30.1M | 29.6M | 34.4M | 30M | 28.8M | 29.1M |
Add to Watchlist
Select watchlists to add or remove WST